C0139 Reversal of rivaroxaban-induced prolongation of clotting time with prothrombin complex concentrate (PCC), activated prothrombin complex concentrate (aPCC) and recombinant Factor VIIa (rFVIIa) in vitro

  • Elizabeth Perzborn, Stefan Heitmeier, Volker Laux
  • Thrombosis Research, October 2012, Elsevier
  • DOI: 10.1016/j.thromres.2012.08.037

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/j.thromres.2012.08.037